-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD) Drug Details: Atidarsagene autotemcel (libmeldy) is a gene therapy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SGT-001 in Duchenne Muscular Dystrophy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SGT-001 in Duchenne Muscular Dystrophy Drug Details: SGT-001 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PTG-007 in Relapsing Remitting Multiple Sclerosis (RRMS)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PTG-007 in Relapsing Remitting Multiple Sclerosis (RRMS) Drug Details: PTG-007 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PTG-007 in Primary Progressive Multiple Sclerosis (PPMS)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PTG-007 in Primary Progressive Multiple Sclerosis (PPMS) Drug Details: PTG-007 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VCAR33 (Autologous) in Refractory Acute Myeloid Leukemia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VCAR33 (Autologous) in Refractory Acute Myeloid Leukemia Drug Details: VCAR-33 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VCAR33 (Autologous) in Relapsed Acute Myeloid Leukemia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VCAR33 (Autologous) in Relapsed Acute Myeloid Leukemia Drug Details: VCAR-33 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBAC-01 in Stroke
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CBAC-01 in Stroke Drug Details: CBAC-01 is under development for the treatment of stroke,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fremanezumab in Rosacea
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Fremanezumab in Rosacea Drug Details: Fremanezumab (Ajovy / Adjovi) is a fully humanized IgG2a/kappa monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Primary Humoral Immune Deficiencies
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Primary Humoral Immune Deficiencies Drug Details: Human normal immunoglobulin (Globulin SN, Globulin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Glucarpidase in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Glucarpidase in Diffuse Large B-Cell Lymphoma Drug Details: Glucarpidase (Voraxaze, Megludase) is a carboxypeptidase produced...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bempedoic Acid in Hyperlipidemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bempedoic Acid in Hyperlipidemia Drug Details: Bempedoic acid (Nexletol) is a non-statin lipid lowering agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bempedoic Acid in Hypercholesterolemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bempedoic Acid in Hypercholesterolemia Drug Details: Bempedoic acid (Nexletol) is a non-statin lipid lowering agent....
-
Product Insights
Texas Children’s Hosp – Women and Children’s Hospital – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Texas Children's Hosp - Women and Children's Hospital - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Seattle Children’s – Seattle Children’s Hospital Expansion – Washington
Equip yourself with the essential tools needed to make informed and profitable decisions with our Seattle Children's - Seattle Children's Hospital Expansion - Washington report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Beijing Childrens Hosp Grp – Zhangzhou Children’s Hospital – Fujian
Equip yourself with the essential tools needed to make informed and profitable decisions with our Beijing Childrens Hosp Grp - Zhangzhou Children's Hospital - Fujian report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Phoenix Children Hosp – Phoenix Children’s Hospital – Arrowhead Campus – Arizona
Equip yourself with the essential tools needed to make informed and profitable decisions with our Phoenix Children Hosp - Phoenix ChildrenÂ’s Hospital - Arrowhead Campus - Arizona report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Texas Children’s Hosp – North Austin Hospital for Children and Women – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Texas Children's Hosp - North Austin Hospital for Children and Women - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Xi’an Children’s Hosp – Xi’an Children’s Hospital Jingkai District Branch – Shaanxi
Equip yourself with the essential tools needed to make informed and profitable decisions with our Xi'an Children's Hosp - Xi'an Children's Hospital Jingkai District Branch - Shaanxi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Children’s Hosp of Richmond/ VCU Health Sys – Children’s Hospital of Richmond – Virginia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Children's Hosp of Richmond/ VCU Health Sys - Children's Hospital of Richmond - Virginia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...